
Abacus Life, Inc. (NASDAQ:ABL – Free Report) – Stock analysts at Northland Capmk increased their Q4 2025 earnings estimates for Abacus Life in a research note issued to investors on Friday, November 7th. Northland Capmk analyst M. Grondahl now anticipates that the company will post earnings of $0.22 per share for the quarter, up from their prior estimate of $0.21. The consensus estimate for Abacus Life’s current full-year earnings is $0.62 per share. Northland Capmk also issued estimates for Abacus Life’s Q1 2026 earnings at $0.23 EPS, Q2 2026 earnings at $0.26 EPS, Q3 2026 earnings at $0.28 EPS, Q4 2026 earnings at $0.29 EPS and FY2026 earnings at $1.05 EPS.
A number of other research firms also recently commented on ABL. Weiss Ratings reiterated a “sell (e+)” rating on shares of Abacus Life in a research report on Wednesday, October 8th. Piper Sandler cut their price target on Abacus Life from $10.00 to $9.00 and set an “overweight” rating for the company in a research note on Thursday, October 9th. Wall Street Zen raised shares of Abacus Life from a “hold” rating to a “buy” rating in a research note on Saturday, August 9th. Finally, B. Riley upgraded shares of Abacus Life to a “strong-buy” rating in a research report on Friday, November 7th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $12.67.
Abacus Life Stock Performance
ABL opened at $6.71 on Monday. Abacus Life has a 1-year low of $4.60 and a 1-year high of $9.61. The stock has a market cap of $649.26 million, a P/E ratio of 83.88 and a beta of -0.02. The stock’s 50 day simple moving average is $5.96 and its 200 day simple moving average is $6.32. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.93 and a quick ratio of 0.76.
Abacus Life (NASDAQ:ABL – Get Free Report) last posted its quarterly earnings results on Thursday, November 6th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.18 by $0.02. The company had revenue of $62.98 million during the quarter, compared to the consensus estimate of $47.42 million. Abacus Life had a net margin of 5.62% and a return on equity of 16.90%.
Abacus Life Dividend Announcement
The company also recently disclosed an annual dividend, which will be paid on Wednesday, December 17th. Stockholders of record on Tuesday, December 2nd will be given a $0.20 dividend. This represents a dividend yield of 310.0%. The ex-dividend date of this dividend is Tuesday, December 2nd.
Hedge Funds Weigh In On Abacus Life
Several institutional investors and hedge funds have recently modified their holdings of ABL. Vanguard Group Inc. grew its stake in Abacus Life by 97.8% in the 3rd quarter. Vanguard Group Inc. now owns 2,456,067 shares of the company’s stock worth $14,073,000 after acquiring an additional 1,214,422 shares during the period. CSM Advisors LLC acquired a new stake in shares of Abacus Life during the second quarter worth $4,138,000. Bastion Asset Management Inc. acquired a new stake in shares of Abacus Life during the first quarter worth $4,353,000. Royce & Associates LP grew its position in shares of Abacus Life by 39.6% in the first quarter. Royce & Associates LP now owns 1,824,253 shares of the company’s stock valued at $13,664,000 after purchasing an additional 517,822 shares during the period. Finally, Marshall Wace LLP increased its stake in Abacus Life by 175.5% in the second quarter. Marshall Wace LLP now owns 657,251 shares of the company’s stock valued at $3,378,000 after purchasing an additional 418,660 shares during the last quarter.
Abacus Life Company Profile
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
Recommended Stories
- Five stocks we like better than Abacus Life
- How to Use Stock Screeners to Find Stocks
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- The Role Economic Reports Play in a Successful Investment Strategy
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
- Why Are These Companies Considered Blue Chips?
- BigBear.ai Stock Is Range-Bound—Wall Street Isn’t Buying the Hype
Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter.
